Standout Papers

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy 2017 2026 2020 2023 745
  1. Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy (2017)
    Robert Zeiser, Bruce R. Blazar New England Journal of Medicine
  2. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease (2020)
    Robert Zeiser, Nikolas von Bubnoff et al. New England Journal of Medicine
  3. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets (2017)
    Robert Zeiser, Bruce R. Blazar New England Journal of Medicine
  4. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease (2021)
    Robert Zeiser, Nicola Polverelli et al. New England Journal of Medicine

Immediate Impact

6 by Nobel laureates 7 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
2024 Standout
Nutrients: Signal 4 in T cell immunity
2024 Standout
5 intermediate papers

Works of Robert Zeiser being referenced

Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy
2020
Immune modulatory effects of statins
2018
and 2 more

Author Peers

Author Last Decade Papers Cites
Robert Zeiser 4354 5019 2699 2726 278 11.0k
Pavan Reddy 6004 5656 1592 2250 205 10.0k
Jürgen Finke 6783 3386 3722 1722 393 12.6k
Ulrich Dührsen 3030 3184 2947 2200 283 10.1k
R.J. Arceci 2994 1945 3514 5071 389 12.3k
Robert A. Brodsky 5415 7116 1136 1729 259 12.9k
William Krivit 4138 1855 1678 3589 279 14.4k
Robert F. Todd 2279 4273 1016 2727 151 10.9k
Hendrik Schulze‐Koops 1560 3450 1251 1668 263 9.0k
David J. Rawlings 1519 9453 2334 5136 257 16.1k
Claudio Tripodo 809 4515 2754 2959 243 10.2k

All Works

Loading papers...

Rankless by CCL
2026